欢迎访问《中国循证儿科杂志》官方网站，今天是
English Version
中国循证儿科杂志

中国循证儿科杂志 ›› 2018, Vol. 13 ›› Issue (3): 194-196.

• 论著 • 上一篇    下一篇

2016年中国大陆期刊发表临床实践指南的报告质量评价

柯立鑫1,9,王津京2,9,王浩3,肖玉洁3,王子君3,车刚1,刘练3,童雅婧4,罗旭飞5,6,7,8,卢存存5,6,7,8,母义明2,陈耀龙5,6,7,8   

  1. 1 兰州大学第一临床医学院兰州，730000；2 中国人民解放军总医院内分泌科北京，1008532；3 兰州大学第二临床医学院兰州，730000；4 兰州大学公共卫生学院兰州，730000；5 兰州大学循证医学中心，基础医学院兰州，730000；6 甘肃省循证医学与临床转化重点实验室兰州，730000；7 GRADE中国中心兰州，730000；8.WHO指南实施与知识转化合作中心兰州，730000；9.共同第一作者

  • 收稿日期:2018-04-28 修回日期:2018-06-25 出版日期:2018-06-24 发布日期:2018-06-25
  • 通讯作者: 陈耀龙

Reporting quality evaluation of clinical practice guidelines published in journals of mainland China in 2016

KE Li-xin 1,9, WANG Jin-Jing2 ,9, WANG Hao 3, XIAO Yu-jie 3, WANG Zi-jun 3 , CHE Gang 1, LIU Lian 3, TONG Ya-jing 4 , LUO Xu-fei 5,6,7,8, LU Cun-cun 5,6,7,8, MU Yi-ming 2, CHEN Yao-long 5,6,7,8#br#   

  1. 1. The First Clinical Medical School, Lanzhou University, Lanzhou 730000, China; 2. Department of Endocrinology, PLA General Hospital, Beijing 1008532, China; 3. The Second Clinical Medical School, Lanzhou University, Lanzhou 730000, China; 4. School of Public Health, Lanzhou University, Lanzhou 730000, China; 5. Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China; 6. Key Laboratory of Evidence-based Medicine and Knowledge Translation of Gansu Province, Lanzhou 730000, China; 7. GRADE Chinese Center, Lanzhou 730000, China; 8.WHO Collaborating Center for Guideline Implementation and Knowledge Translation, Lanzhou 730000, China; 9. Co-first author
  • Received:2018-04-28 Revised:2018-06-25 Online:2018-06-24 Published:2018-06-25
  • Contact: CHEN Yao-long

PDF

803

摘要： 目的：使用国际实践指南报告标准（RIGHT）评价2016年中国大陆期刊发表的临床实践指南的报告质量，为中国学者报告指南提供参考。方法：计算机检索中国生物医学文献服务系统（CBM）、中国知网（CNKI）和万方数据库（Wan Fang Data），收集期刊公开发表的中国大陆临床实践指南，检索时限为2016年1月1日至2016年12月31日。由2位评价员独立筛选文献，提取资料并交叉核对，用Office Excel 2016软件处理数据。结果：共纳入指南79篇。领域1（基本信息）的报告率最高（52.7%），领域5（评审和质量保证）和领域7（其他方面）的报告率最低（6.3%）。79篇指南均报告了条目1a（能否通过题目判断为指南），均未报告条目9a-1（如何遴选参与指南制订的所有贡献者）、条目11b-1（已发表系统评价的检索与评价）、条目11b-2（是否对系统评价进行更新）、条目14a（是否考虑目标人群的价值观和偏好）、条目17（是否经过质量控制程序）和条目18b（推荐意见的传播和实施）。结论：2016年中国大陆期刊指南总体报告质量不佳，建议在以后指南制订过程中参考RIGHT规范对指南进行报告。

Abstract: Objective：To evaluate the reporting quality of clinical practice guidelines published in journals of mainland China in 2016, using Reporting Items for practice Guidelines in Healthcare (RIGHT) , in order to provide reference for Chinese scholars in reporting guidelines. Methods：The electronic databases of CBM (Chinese Biomedical Literature Database), CNKI (China National Knowledge Infrastructure) and Wan Fang Database from January to December 2016 were searched. Two authors independently selected studies, extracted data and the data was processed by Excel 2016 software. Results：Seventy-nine clinical practice guidelines were included. We found that among the seven domains of RIGHT, field one (basic information) had the highest reporting rate (52.7%). Field five (review and quality assurance) and field seven (funding, declaration and management of interest) had the lowest reporting rate (6.3%). All guidelines reported item 1a (identify the report as a guideline in the title). None of the guidelines reported item 9a-1 (how all contributors to the guideline development were selected), item 11b-1 (if the guideline developers used existing systematic reviews, reference these and describe how those reviews were identified and assessed), item 11b-2 (whether systematic reviews were updated), item 14a (whether values and preferences of the target population(s) were considered in the formulation of each recommendation), item 17 (whether the guideline was subjected to a quality assurance process) and item 18b (describe the role of funder(s) in the different stages of guideline development and in the dissemination and implementation of the recommendations). Conclusion：The reporting quality of clinical practice guidelines published in journals of mainland China in 2016 is low. It is suggested that the guideline developers should report guidelines in accordance with RIGHT during the guideline development process.